aflibercept
Eylea (Anti-VEGF)
Plain-language definition
An anti-VEGF fusion protein injected into the eye for wet AMD, diabetic macular edema, and retinal vein occlusions. Brand name: Eylea.
Expanded explanation
aflibercept is the glossary term for Eylea (Anti-VEGF). On a full article page, it should be read as a medication term, not as a stand-alone diagnosis or treatment plan.
Medication terms identify a drug, drug class, or treatment ingredient. The useful context is why it is being used, how it is taken, what benefit is expected, and what safety issues need monitoring.
In eye care context
Medication terms describe drugs or drug classes that may be used in eye care, neurology, inflammation, infection, or pain treatment.
What to look for around this term
- Whether the medication is being used for inflammation, infection, pressure control, pain, immune suppression, migraine, or another purpose.
- The route of treatment, such as eye drop, pill, injection, infusion, ointment, or nasal spray.
- Expected benefits, common side effects, contraindications, and follow-up monitoring.
Questions this term may raise
- What problem is this medication treating?
- How quickly should it help?
- What side effects or interactions should be reviewed?
- Category
- Medication
- Also written as
- No alternate forms listed.
Related glossary terms
- acyclovir
Herpes Antiviral
- anti-VEGF
Anti-Vascular Endothelial Growth Factor
- antidepressant
Mood-Regulating Drug
- antihistamine
Allergy-Blocking Drug
- antiplatelet
Blood Clot-Preventing Drug
- antiseptic
Germ-Killing Agent
A note on medical context
A glossary definition can explain a word, but it cannot tell you whether a symptom or test result is serious. If this term came from an article, use the full article and your clinician's guidance for context.